SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-073492
Filing Date
2022-11-17
Accepted
2022-11-17 16:10:05
Documents
15
Period of Report
2022-11-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea168928-8k_inmedpharma.htm   iXBRL 8-K 32052
2 NEWS RELEASE, DATED NOVEMBER 17, 2022 ea168928ex99-1_inmedpharma.htm EX-99.1 9310
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5102
  Complete submission text file 0001213900-22-073492.txt   267227

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20221117.xsd EX-101.SCH 3470
5 XBRL DEFINITION FILE inm-20221117_def.xml EX-101.DEF 26195
6 XBRL LABEL FILE inm-20221117_lab.xml EX-101.LAB 35952
7 XBRL PRESENTATION FILE inm-20221117_pre.xml EX-101.PRE 24853
9 EXTRACTED XBRL INSTANCE DOCUMENT ea168928-8k_inmedpharma_htm.xml XML 4308
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 221398464
SIC: 2834 Pharmaceutical Preparations